/Cooper%20Companies%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
San Ramon, California-based The Cooper Companies, Inc. (COO) is a specialty medical device company that operates through CooperVision and CooperSurgical segments. CooperVision focuses on the manufacturing and sale of contact lenses, while CooperSurgical provides a variety of medical devices and surgical instruments. With a market cap of $21.5 billion, Cooper’s operations span the Americas, Indo-Pacific, Europe, and internationally. COO is set to announce its Q4 earnings on Thursday, Dec. 5.
Ahead of the event, analysts expect Cooper to report a profit of $1 per share, up 14.9% from $0.87 per share reported in the year-ago quarter. The company has matched or surpassed Wall Street’s earnings estimates in the past four quarters. Its adjusted EPS for the last reported quarter grew 14.3% year-over-year to $0.96, exceeding the consensus estimates by 5.5%.